Sarossa plc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Sarossa plc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013604
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sarossa plc (Sarossa), formerly Sarossa Capital Limited, is an investment holding and management company. The company principally makes investment in and growth and development of businesses which present opportunities for value creation. It focuses on portfolio investment in major international markets through its partners and customers with an international profile. It has holdings in Silence Therapeutics Plc, a novel RNAi therapeutics development company; Plant Health Care Plc, a provider of novel patent protected biological products to the global agriculture markets; Avesoro Resources Inc, handles exploration and development of gold deposits; and Cambian Group Plc, offers specialist behavioral health services for children in the UK. Sarossa is headquartered in Channel Islands, the UK.

Sarossa plc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sarossa plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Sarossa plc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Sarossa plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Sarossa plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Sarossa plc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Sarossa plc, Pharmaceuticals & Healthcare, Deal Details 10
Equity Offering 10
Silence Therapeutics Completes Private Placement Of Shares For US$29 Million 10
Asset Transactions 12
Advanced Cancer Therapeutics Completes Purchase Of AS1411 From Antisoma 12
Biothera Acquires AS1402 From Antisoma 14
Sarossa plc – Key Competitors 15
Sarossa plc – Key Employees 16
Sarossa plc – Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Sarossa plc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Sarossa plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Sarossa plc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Sarossa plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Sarossa plc, Deals By Therapy Area, 2011 to YTD 2017 8
Sarossa plc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Silence Therapeutics Completes Private Placement Of Shares For US$29 Million 10
Advanced Cancer Therapeutics Completes Purchase Of AS1411 From Antisoma 12
Biothera Acquires AS1402 From Antisoma 14
Sarossa plc, Key Competitors 15
Sarossa plc, Key Employees 16

★海外企業調査レポート[Sarossa plc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Acceleron Pharma Inc (XLRN)-製薬・医療分野:企業M&A・提携分析
    Summary Acceleron Pharma Inc (AcceleronPharma) is a clinical stage biopharmaceutical company that discovers, developsand commercializes therapeuticsto treat serious and rare diseases. The company’s lead therapeutic candidate, luspatercept, is in phase 3 studyused for the treatment of the myelodyspla …
  • Yungjin Pharm Co Ltd (003520):製薬・医療:M&Aディール及び事業提携情報
    Summary Yungjin Pharm Co Ltd (Yungjin), a subsidiary of KT&G Corp is a pharmaceutical company that develops, manufactures and distributes active pharmaceutical ingredients, formulations and tonic drinks. The company provides API products such as cephalosporins and other general products. It also off …
  • Avcorp Industries Inc:企業の戦略・SWOT・財務情報
    Avcorp Industries Inc - Strategy, SWOT and Corporate Finance Report Summary Avcorp Industries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Polar Power Inc (POLA):企業の財務・戦略的SWOT分析
    Polar Power Inc (POLA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Smith & Nephew Plc (SN.):医療機器:M&Aディール及び事業提携情報
    Summary Smith & Nephew Plc (Smith & Nephew) is a medical technology company that develops, manufactures and markets medical devices for use in orthopaedic reconstruction and trauma, sports medicines and advanced wound management. The company offers its products in various categories including Sports …
  • Neuron Biopharma SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Neuron Biopharma SA (NBP) is a biotechnology company that discovers and develops biosolutions. The company offers pharmaceutical compounds to prevent and treat various neurodegenerative diseases. It discovers and assesses nutraceuticals, and development of diagnostic methods for the treatmen …
  • CEL-SCI Corp (CVM):企業の財務・戦略的SWOT分析
    CEL-SCI Corp (CVM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • American Woodmark Corp (AMWD):企業の財務・戦略的SWOT分析
    American Woodmark Corp (AMWD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Sutro Biopharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Sutro Biopharma Inc (Sutro Biopharma), formerly Fundamental Applied Biology Inc, discovers, develops and manufactures novel cancer medicines which include antibody-drug conjugates (ADC’s), bispecific antibodies, and antibody-based therapeutics targeting immuno-oncology pathways. Its pipeline …
  • NeuroLogica Corp-医療機器分野:企業M&A・提携分析
    Summary NeuroLogica Corp (NeuroLogica), a subsidiary of Samsung Electronics America Inc is a medical device company that develops, manufactures and markets medical imaging equipment. The company offers digital radiography systems for hospitals and imaging centers, portable CT imaging systems, and ul …
  • Critical Outcome Technologies Inc (COT)-製薬・医療分野:企業M&A・提携分析
    Summary Critical Outcome Technologies Inc (COTI) is a biopharmaceutical company that develops targeted therapeutics with focus on oncology. The company’s lead program COTI-2 is a novel small molecule activator of misfolded mutant p53 proteins for the treatment of ovarian and other gynecological canc …
  • UNeMed Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Unemed Corp (Unemed), a subsidiary of University of Nebraska Medical Center, is a healthcare service provider. The company offers services such as inventions, material transfer, confidentiality, intellectual property, startup formation and licensing process. Its technologies include therapeu …
  • FTI Consulting, Inc.:企業の戦略・SWOT・財務情報
    FTI Consulting, Inc. - Strategy, SWOT and Corporate Finance Report Summary FTI Consulting, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Boardwalk Pipeline Partners LP:企業の戦略・SWOT・財務情報
    Boardwalk Pipeline Partners LP - Strategy, SWOT and Corporate Finance Report Summary Boardwalk Pipeline Partners LP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Check Point Software Technologies Ltd.:企業の戦略・SWOT・財務分析
    Check Point Software Technologies Ltd. - Strategy, SWOT and Corporate Finance Report Summary Check Point Software Technologies Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Israel Chemicals Ltd.:企業の戦略・SWOT・財務情報
    Israel Chemicals Ltd. - Strategy, SWOT and Corporate Finance Report Summary Israel Chemicals Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Canadian Cancer Trials Group-製薬・医療分野:企業M&A・提携分析
    Summary Canadian Cancer Trials Group (CCTG), formerly known as NCIC Clinical Trials Group, is a subsidiary of Cancer Research Institute at Queen's University, is a contract research organization that conducts clinical trials. The organization conducts trials for the development of new drugs and ther …
  • National Fuel Gas Co Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    National Fuel Gas Co Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary National Fuel Gas Co (National Fuel) is a diversified energy company that specializes in the production, gathering, transportation, distribution and marketing of natural gas. It operates as an integ …
  • CAS Medical Systems Inc (CASM):医療機器:M&Aディール及び事業提携情報
    Summary CAS Medical Systems Inc (CASMED) is a medical device company that designs, manufactures and markets technologies and monitors. The company offers technologies and monitors that deliver patient data. Its products comprise FORE-SIGHT absolute tissue oximeter, blood pressure measurement technol …
  • Boardwalk Pipeline Partners LP:企業のM&A・事業提携・投資動向
    Boardwalk Pipeline Partners LP - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Boardwalk Pipeline Partners LP Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆